title: Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
abstract: Adynamic bone disease (ABD) is frequently associated with low serum parathyroid hormone (PTH) concentrations. Many clinical and therapeutic conditions have been associated with ABD, and recently, a low phosphorus intake accompanied by low serum concentration of phosphorus and PTH has been described.
  
  
  OBJECTIVE
  To evaluate the parathyroid gland response of chronic renal insufficiency patients (CRI) with low serum PTH or ABD to a phosphorus load.
  
  
  METHODS
  We examined the effects of 0.5 and 1.0 g/d of phosphorus load over a period of 60 days in 18 patients with mild CRI with a bone biopsy showing ABD (n = 7) or with low serum PTH (serum intact PTH < or = 40 ng/l) and serum phosphorus < 4.5 mg/dl (n = 11).
  
  
  RESULTS
  Serum intact PTH increased significantly only after 1 g of phosphorus (58.5 to 83 ng/l) with a median percent increase of 72%. PTH secretion increased more in patients with lower basal PTH levels (81%). Serum phosphorus did not change significantly and urinary phosphorus increased from 487 to 1,062 mg/dl (p < 0.05). Significant decreases in serum ionized calcium (from 1.26 to 1.19 mmol/l) and calcitriol (from 34.5 to 24.9 pg/ml) were observed. Changes in PTH were inversely correlated with changes in serum ionized calcium (r = -0.54, p < 0.05) and the final PTH concentrations were positively correlated with changes in serum phosphorus (r= 0.52, p < 0.05).
  
  
  CONCLUSIONS
  The parathyroid glands of chronic renal insufficiency patients with "relative hypoparathyroidism" or ABD responded to a phosphorus load with an increase in serum PTH levels. The decrease in serum ionized calcium and calcitriol as well as minimal changes in serum phosphorus appeared to be involved in this response.
authors.affiliation: Division of Nephrology, Escola Paulista de Medicina, Federal University of São Paulo, Brazil.
authors.forename: L
authors.initials: L
authors.lastname: Cuppari
authors.forename: A B
authors.initials: AB
authors.lastname: Carvalho
authors.forename: R R
authors.initials: RR
authors.lastname: Lobão
authors.forename: L A
authors.initials: LA
authors.lastname: Martini
authors.forename: M
authors.initials: M
authors.lastname: Cendoroglo
authors.forename: R T
authors.initials: RT
authors.lastname: Ventura
authors.forename: S A
authors.initials: SA
authors.lastname: Draibe
mesh_terms: D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D000886:Anthropometry; D015519:Bone Density; D001847:Bone Diseases / Q000097:blood*; D002117:Calcitriol / Q000097:blood; D002118:Calcium / Q000097:blood; D005260:Female; D006801:Humans; D007011:Hypoparathyroidism / Q000097:blood*; D007676:Kidney Failure, Chronic / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood*; D010758:Phosphorus / Q000627:therapeutic use*; D018709:Statistics, Nonparametric
chemical_list: D010281:Parathyroid Hormone; D010758:Phosphorus; D002117:Calcitriol; D002118:Calcium